tiprankstipranks
Advertisement
Advertisement
Spruce Biosciences price target lowered to $144 from $150 at Citizens
PremiumThe FlySpruce Biosciences price target lowered to $144 from $150 at Citizens
18d ago
Spruce Biosciences appoints Jessica Cohen Pfeffer as VP, clinical development
Premium
The Fly
Spruce Biosciences appoints Jessica Cohen Pfeffer as VP, clinical development
1M ago
Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus
Premium
Company Announcements
Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus
1M ago
Spruce Biosciences joins Russell 3000 Index
PremiumThe FlySpruce Biosciences joins Russell 3000 Index
2M ago
Spruce Biosciences appoints Agnieszka Jurecka as VP, medical affairs
Premium
The Fly
Spruce Biosciences appoints Agnieszka Jurecka as VP, medical affairs
2M ago
Spruce Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Spruce Biosciences initiated with a Buy at Guggenheim
3M ago
Spruce Biosciences price target lowered to $150 from $200 at H.C. Wainwright
PremiumThe FlySpruce Biosciences price target lowered to $150 from $200 at H.C. Wainwright
3M ago
Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay
Premium
Company Announcements
Spruce Biosciences Stockholders Approve Directors and Annual Say-on-Pay
3M ago
Spruce Biosciences price target lowered to $150 from $170 at Citizens
Premium
The Fly
Spruce Biosciences price target lowered to $150 from $170 at Citizens
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100